Teva Pharmaceutical Industries Limited logo

Teva Pharmaceutical Industries Limited

TEVA | NYSE
Chart Builder DCF Calculator
$39.47
-$0.59 (-1.47%)
Sep 22, 2026, 2:37 PM ET · Market open

Market Data

Market Cap
$46.66B
Enterprise Value
$59.87B
Beta
0.87
Average Volume
6.06M
Shares Outstanding (Diluted)
1.18B
Shares Change YoY
1.72%
Institutional Ownership
58.28%
Exchange
NYSE
ISIN
US8816242098

Price Performance

Price Change 1M
7.3%
Price Change 3M
20.6%
Price Change 6M
36.0%
Price Change YTD
29.4%
Price Change 1Y
112.3%
Price Change 3Y
287.1%
Price Change 5Y
347.6%
1M CAGR (ann.)
13.3%
1Y CAGR (ann.)
117.1%
5Y CAGR (ann.)
34.0%
All-Time CAGR
2.3%

Valuation

PE Ratio
66.77
Forward PE
12.80
PEG Ratio
0.12
Forward PEG
1.16
PS Ratio
2.69
Forward PS
2.70
PB Ratio
6.01
P/FCF Ratio
31.24
P/Adj. FCF Ratio
34.16
P/OCF Ratio
15.90
EV/Sales
3.46
EV/EBIT
29.73
EV/EBITDA
19.88
EV/FCF
40.09
Earnings Yield
1.5%
FCF Yield
3.2%
Adj. FCF Yield
2.9%

Financial Health

Net Debt
$12.94B
Total Debt
$16.87B
Cash & Short-Term Investments
$3.66B
Total Assets
$39.86B
Current Ratio
0.88
Quick Ratio
0.67
Debt / Equity Ratio
2.16
Debt / EBITDA
5.60
Debt / FCF
11.30
OCF / Debt
0.12
Interest Coverage
2.99
Altman Z-Score
0.93
Piotroski F-Score
7

Margins & Profitability

Gross Profit Margin
52.5%
Operating Profit Margin
11.4%
EBITDA Margin
17.7%
Net Profit Margin
4.1%
FCF Margin
8.6%
Adj. FCF Margin
7.9%
SBC / Revenue
0.7%
SBC Impact (per share)
-8.6%

Returns

Return on Assets
1.8%
Return on Equity
9.2%
Return on Invested Capital
9.0%
Return on Capital Employed
10.7%
Return on Tangible Assets
3.5%

Historical Growth (CAGR)

Revenue CAGR 3Y
4.9%
Revenue CAGR 5Y
1.2%
Revenue CAGR 10Y
-1.2%
EPS CAGR 3Y
2970.0%
EPS CAGR 5Y
84.9%
EPS CAGR 10Y
-9.2%
FCF CAGR 3Y
8.4%
FCF CAGR 5Y
18.6%
FCF CAGR 10Y
-10.0%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
46
EPS Growth Next 3Y
82.7%
Revenue Growth Next 3Y
3.2%
Earnings Date
Nov 3, 2026
EPS Estimate (next Q)
$0.70
EPS Growth Est (next Q)
-10.4%
Revenue Est (next Q)
$4.26B
Revenue Growth Est (next Q)
-5.0%

Fair Value Estimates

Graham Number
$9.48
Graham Upside
-76.3%
Lynch Fair Value
$15
Lynch Upside
-62.6%
Price Target
$44.75
Price Target Upside
11.7%

Cash Flow

Operating Cash Flow
$2.05B
Free Cash Flow
$1.49B
Adj. Free Cash Flow
$1.37B
FCF Per Share
$2.04
OCF Per Share
$2.52
OCF/S Ratio
16.9%

Income Statement

Revenue
$17.31B
Gross Profit
$9.09B
Operating Income
$1.98B
EBITDA
$3.01B
Net Income
$706M
EPS (Diluted)
$0.60
Revenue / Employee
$540.93K
Profit / Employee
$22.06K
Employees
32,008

© 2026 bestshares.com. All rights reserved.